CDIVX
Price
$12.29
Change
+$0.09 (+0.74%)
Updated
Jun 6 closing price
Net Assets
30.22M
FSMAX
Price
$90.60
Change
+$1.13 (+1.26%)
Updated
Jun 6 closing price
Net Assets
37.61B
Interact to see
Advertisement

CDIVX vs FSMAX

Header iconCDIVX vs FSMAX Comparison
Open Charts CDIVX vs FSMAXBanner chart's image
Copeland Dividend Growth Fund
Price$12.29
Change+$0.09 (+0.74%)
VolumeN/A
Net Assets30.22M
Fidelity Extended Market Index
Price$90.60
Change+$1.13 (+1.26%)
VolumeN/A
Net Assets37.61B
CDIVX vs FSMAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CDIVX vs. FSMAX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CDIVX is a Buy and FSMAX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 37.6B vs. CDIVX (30.2M). FSMAX pays higher dividends than CDIVX: FSMAX (0.50) vs CDIVX (0.27). CDIVX was incepted earlier than FSMAX: CDIVX (12 years) vs FSMAX (14 years). CDIVX (1.99) is less costly to investors than FSMAX (0.04). CDIVX is a more actively managed with annual turnover of: 32.00 vs. FSMAX (9.00). FSMAX has a lower initial minimum investment than CDIVX: FSMAX (0) vs CDIVX (25000). FSMAX annual gain was more profitable for investors over the last year : 11.97 vs. CDIVX (-5.25). FSMAX return over 5 years is better than : 51.39 vs. CDIVX (16.95).
CDIVXFSMAXCDIVX / FSMAX
Total Expense Ratio1.050.043,000%
Annual Report Gross Expense Ratio1.990.045,686%
Fund Existence12 years14 years-
Gain YTD1.161-1.551-75%
Front LoadN/AN/A-
Min. Initial Investment250000-
Min. Initial Investment IRAN/AN/A-
Net Assets30.2M37.6B0%
Annual Yield % from dividends0.270.5054%
Returns for 1 year-5.2511.97-44%
Returns for 3 years1.9130.476%
Returns for 5 years16.9551.3933%
Returns for 10 years-13.6969.53-20%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LOGSX20.56N/A
N/A
Live Oak Health Sciences
OEQIX8.34N/A
N/A
Oaktree Emerging Markets Equity I
POVSX29.69N/A
N/A
Putnam International Equity A
ABYSX20.41N/A
N/A
AB Discovery Value Advisor
AKREX69.19N/A
N/A
Akre Focus Retail